Meng Xie
- Aging top 5%
- Genetics, Aging, and Longevity in Model Organisms 2
- Rheumatology top 10%
-
- Lipid metabolism and biosynthesis 3
-
- Adipose Tissue and Metabolism 6
-
- Immune Cell Function and Interaction 3
- interferon and immune responses 2
-
- Cardiovascular Disease and Adiposity 2
-
- Connective tissue disorders research 2
-
- Neuroinflammation and Neurodegeneration Mechanisms 2
- Co-authors
- Jin‐Ping LiRichard RoyAndrei S. ChaginYingyi LuanNing DongYong-ming YaoXianzhong XiaoIgor Adameyko
- Cited by
- AgingRheumatologyBiochemistry
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nature Communications (1 paper)PLoS ONE (3 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Meng Xie
31 papers receiving 578 citations
Peers
Comparison fields: 5 of 112
- Aging 46
- Rheumatology 89
- Biochemistry 32
- Cell Biology 68
- Immunology and Allergy 23
Countries citing papers authored by Meng Xie
This map shows the geographic impact of Meng Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Xie more than expected).
Fields of papers citing papers by Meng Xie
This network shows the impact of papers produced by Meng Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Xie. The network helps show where Meng Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meng Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 4 | |
| 8 | 2021 | 4 | |
| 9 | 2020 | 1 | |
| 10 | 2020 | 7 | |
| 11 | 2020 | 8 | |
| 12 | 2019 | 36 | |
| 13 | 2018 | 71 | |
| 14 | 2018 | 17 | |
| 15 | 2015 | 18 | |
| 16 | 2015 | 8 | |
| 17 | 2013 | 73 | |
| 18 | 2012 | 53 | |
| 19 | 2011 | 11 | |
| 20 | A patient with four different kinds of skin tumors on the forehead. | 1992 | 0 |
About Meng Xie
Meng Xie is a scholar working on Aging, Biochemistry and Critical Care and Intensive Care Medicine, having authored 33 papers that have together received 582 indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (6 papers), Lipid metabolism and biosynthesis (3 papers), Immune Cell Function and Interaction (3 papers), interferon and immune responses (2 papers), Cardiovascular Disease and Adiposity (2 papers), Genetics, Aging, and Longevity in Model Organisms (2 papers), Connective tissue disorders research (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). The work is most often cited by research in Aging (46 citations), Rheumatology (89 citations) and Biochemistry (32 citations). Meng Xie has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Jin‐Ping Li, Richard Roy, Andrei S. Chagin, Richard Roy, Yingyi Luan, Ning Dong, Yong-ming Yao, Xianzhong Xiao, Igor Adameyko and Vyacheslav Dyachuk. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.